NEJM -- Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America: "Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America Jacob P. Lalezari, M.D., Keith Henry, M.D., Mary O'Hearn, M.D., Julio S.G. Montaner, M.D., Peter J. Piliero, M.D., Benôit Trottier, M.D., Sharon Walmsley, M.D., Calvin Cohen, M.D., Daniel R. Kuritzkes, M.D., Joseph J. Eron, Jr., M.D., Jain Chung, Ph.D., Ralph DeMasi, Ph.D., Lucille Donatacci, M.S., Claude Drobnes, M.D., John Delehanty, Ph.D., Miklos Salgo, M.D., Ph.D., for the TORO 1 Study Group"

This might prove to be the wonder-drug we've been searching for! - KK